Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas
- Citation:
- JAMA Oncol vol 8 (9) 1263-1270
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3424
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171; UG1CA189960, UG1CA233180, UG1CA233290, UG1CA233329, UG1CA233331, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Matthew H. G. Katz Qian Shi Jeff Meyers Joseph M. Herman Michael Chuong Brian M. Wolpin Syed Ahmad Robert Marsh Larry Schwartz Spencer Behr Wendy L. Frankel Eric Collisson James Leenstra Terence M. Williams Gina Vaccaro Alan Venook Jeffrey A. Meyerhardt Eileen M. O'Reilly
- Networks:
- CA043, CA824, IL018, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-OH007, LAPS-TX035, MD015, NORTHWELL, OH070, PCRC
- Study
- Alliance-A021501
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Research, Research, Original Investigation, Featured, Online First, Comments